Home › Cancer (all types) › NCT05120518
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
RecruitingObservational study
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Pediatric patients with cancer and non-cancer tumor types (solid, liquid, neuro-oncology) * Signed consent for post mortem tissue donation and autopsy Exclusion Criteria: * Signed consent for post mortem tissue donation and autopsy not obtained
About the study
The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).
What is being tested
- Collection of post mortem tissue donation (other)
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago · Participants: 150 · Started: Aug 14, 2019
Contact the study team
- Angela Waanders, MD · Phone: 312-227-4090
- Melissa Williams, BA · Phone: 312-227-3893
Official record on ClinicalTrials.gov — NCT05120518
Locations in the U.S.
| Illinois | Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.